Cohort Study | Polygenic risk score improves the accuracy of a clinical risk score for coronary artery disease.
23 Nov, 2022 | 13:55h | UTCRelated:
AHA Scientific Statement | Polygenic risk scores for cardiovascular disease.
Cohort Study | Polygenic risk, midlife life’s simple 7, and lifetime risk of stroke.
Cohort Study: A polygenic risk score may improve risk stratification of coronary artery disease.
Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps.
Commentary on Twitter
A #Polygenic risk score improves the accuracy of a clinical risk score for #CoronaryArteryDisease
Read more about improved predictive accuracy for incident CAD in the #UKBiobank at #BMCMedicine https://t.co/8T5RaacnTj pic.twitter.com/vIhg9IGhRv
— BMC Medicine (@BMCMedicine) November 8, 2022